Trials / Recruiting
RecruitingNCT05644431
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
A Prospective Clinicobiological Cohort Study Aiming to Decipher Tumor Immune Microenvironment Evolution Under Standard Chemotherapy in Localized and Resectable Gastric and Gastroesophageal Junctional Adenocarcinomas
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Centre Leon Berard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is a prospective, monocentric, non-therapeutic, interventional cohort study aiming to decipher the immune TME through standard neoadjuvant CT in resectable G/GEJ adenocarcinomas. This study will also longitudinally monitor MRD during neoadjuvant and adjuvant therapy.
Conditions
Timeline
- Start date
- 2023-07-19
- Primary completion
- 2028-01-15
- Completion
- 2028-01-15
- First posted
- 2022-12-09
- Last updated
- 2023-08-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05644431. Inclusion in this directory is not an endorsement.